Healthcare & Medical Devices Global On demand · 24-48h

Global Radiation Therapy Planning System Market Strategic Research Report

Global Radiation Therapy Planning System Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Radiation Therapy Planning System Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Software, Hardware

By Application: Conformal Radiation Therapy, Electron Beam Radiation Therapy, Radiosurgery with Linear Accelerators, Intensity Modulated Radiation Therapy, Other

Key Players: Accuray, Varian, Elekta, Philips Healthcare, RaySearch, Prowess, Linatech, Tecnicas Radiofisicas, DOSIsoft, Nuclemed, Mevis, HoKai, Neusoft Medical Systems Co., Ltd, BEIJING ASTRO TECHNOLOGY LTD.CO

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 110 pages

개요

Scope of the Report

Treatment planning systems are at the heart of radiation therapy (RT) and the key to improved patient outcomes. Once image datasets are loaded and the tumors are identified, the systems develop a complex plan for each beam line route for how the therapy system will deliver radiation. The software also computes the expected dose distribution in the patient’s tissue, including variables such as tissue energy level penetration influenced by the type of tissue the beam lines encounter (e.g., bone or lung vs. muscle). These systems also help navigate beam placement based on avoiding critical structures that are more sensitive to radiation in an effort to reduce collateral damage from the therapy. This may include automated, complex programming for multi-leaf collimator (MLC) leaf sequencing to shape the beam around critical structures during dose delivery. These treatment plans can also be modified to compensate for the reduction in tumor size over the course of treatments.

The global radiation oncology market size was estimated at USD 9.15 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.4% from 2023 to 2030. Radiation therapy is one of the three major technical means to treat malignant tumors. It uses radiation to irradiate and kill tumor tissue cells to achieve the purpose of treatment. Radiation therapy has high requirements on dose control and concentration. In order to achieve higher treatment accuracy, faster treatment speed and realize personalized treatment, precision radiotherapy has been proposed. The radiation is concentrated on the lesion and the dose is increased as much as possible. The rays irradiated by the surrounding normal tissues and organs are reduced as much as possible, which has the advantages of high precision, good curative effect, short time, and small side effects. In the context of precision radiotherapy, radiotherapy planning systems are indispensable, and the market space continues to grow.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Radiation Therapy Planning System market?

What factors are driving Radiation Therapy Planning System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Radiation Therapy Planning System market opportunities vary by end market size?

How does Radiation Therapy Planning System break out by Type, by Application?

This report presents a comprehensive overview of the global Radiation Therapy Planning System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Software
  • Hardware

Segment by Application

  • Conformal Radiation Therapy
  • Electron Beam Radiation Therapy
  • Radiosurgery with Linear Accelerators
  • Intensity Modulated Radiation Therapy
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Radiation Therapy Planning System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Conformal Radiation Therapy, Electron Beam Radiation Therapy, Radiosurgery with Linear Accelerators evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
SoftwareHardware
By Application
Conformal Radiation TherapyElectron Beam Radiation TherapyRadiosurgery with Linear AcceleratorsIntensity Modulated Radiation TherapyOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Software
  • 3.1.3 Hardware
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Conformal Radiation Therapy
  • 4.1.3 Electron Beam Radiation Therapy
  • 4.1.4 Radiosurgery with Linear Accelerators
  • 4.1.5 Intensity Modulated Radiation Therapy
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Accuray
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Varian
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Elekta
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Philips Healthcare
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 RaySearch
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Prowess
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Linatech
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tecnicas Radiofisicas
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 DOSIsoft
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Nuclemed
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Mevis
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 HoKai
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Neusoft Medical Systems Co., Ltd
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 BEIJING ASTRO TECHNOLOGY LTD.CO
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How is Radiation Therapy Planning System defined?
Treatment planning systems are at the heart of radiation therapy (RT) and the key to improved patient outcomes. Once image datasets are loaded and the tumors are identified, the systems develop a complex plan for each beam line route for how the therapy system will deliver radiation. The software also computes the expected dose distribution in the patient’s tissue, including variables such as tissue energy level penetration influenced by the type of tissue the beam lines encounter (e.g., bone or lung vs. muscle).
How is the Radiation Therapy Planning System market segmented by type?
By type, the market is segmented into Software and Hardware.
What are the key applications of Radiation Therapy Planning System?
Key applications covered include Conformal Radiation Therapy, Electron Beam Radiation Therapy, Radiosurgery with Linear Accelerators, Intensity Modulated Radiation Therapy and Other.
Which companies are profiled in the Radiation Therapy Planning System market report?
Key players profiled include Accuray, Varian, Elekta, Philips Healthcare, RaySearch, Prowess, Linatech and Tecnicas Radiofisicas, among 14 companies covered in total.
What geographies does the Radiation Therapy Planning System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Radiation Therapy Planning System?
What factors are driving Radiation Therapy Planning System market growth, globally and by region?
Who should buy the Radiation Therapy Planning System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Conformal Radiation Therapy, Electron Beam Radiation Therapy and Radiosurgery with Linear Accelerators, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Radiation Therapy Planning System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.